Hemoglobin-Based Oxygen Carrier Mitigates Transfusion-Mediated Pancreas Cancer Progression

Lo, Karen; Bey, Erik; Patra, Biswantha; Benson, Douglas; Boothman, David; Silliman, Christopher; Barnett, Carlton
June 2013
Annals of Surgical Oncology: An Oncology Journal for Surgeons;Jun2013, Vol. 20 Issue 6, p2073
Academic Journal
No abstract available.


Related Articles

  • THE DOPE ON BLOOD DOPING. Claps, Frank; Stoppani, Jim // Joe Weider's Muscle & Fitness;Sep2004, Vol. 65 Issue 9, p182 

    Provides information on steroids or artificial oxygen carriers mostly used by athletes. Efforts of sports governing bodies to ban the substance; Effects of the substance on the body; Classifications of artificial oxygen carriers; Detection of hemoglobin-based oxygen carriers and perfluorocarbons.

  • Could oxygen therapeutics offer alternative to trasfusions? LoBuono, Charlotte // Drug Topics;9/16/2002, Vol. 146 Issue 18, pHSE24 

    Discusses ways in which oxygen therapeutics represents a potential category of treatments that may replace blood transfusions. Delivery of oxygen to tissues without having to transfuse blood; Reasons for developing a substitute for blood transfusions; Use of hemoglobin-based oxygen carriers...

  • Oxygen Biotherapeutics and U.S. Navy Expand Collaboration with Cooperative R&D Agreement to Study Oxycyte(r) for Treatment of Hemorrhagic Shock.  // Biomedical Market Newsletter;8/7/2012, Vol. 21, p1 

    The article informs that Oxygen Biotherapeutics Inc. has entered into cooperative research and development agreement with the Naval Medical Research Unit of San Antonio, San Antonio, California. The collaboration is aimed at assessing the safety and efficacy of Oxygen's Oxycyte as well as...

  • ARTIFICIAL OXYGEN CARRIERS: A CURRENT REVIEW. Henkel-Hanke, Thad; Oleck, Mark // AANA Journal;Jun2007, Vol. 75 Issue 3, p205 

    Artificial oxygen carriers are not blood, substitutes. They serve to carry oxygen to tissues and are either hemoglobin based or perfluorocarbon based. Driving the development of artificial oxygen carriers are concerns involving both the safety and quantity of the blood supply. No artificial...

  • Cow's blood saves a life.  // Medical Ethics Advisor;Jun2011, Vol. 27 Issue 6, p70 

    The article reports that a patient named Tamara Coakley who had been in a medically induced coma since a car accident in October 2010, was spared after a life saving transfusion was performed on her using hemoglobin-based oxygen carrier HBOC-201, a product manufactured from cow's blood.

  • Oxycyte on track as oxygen carrier, not blood substitute. Yoffee, Lynn // Medical Device Daily;5/5/2008, Vol. 12 Issue 87, p1 

    This article deals with the clarification issued by Synthetic Blood International (SBI) regarding its flagship product Oxycyte. According to SBI, Oxycyte is not a synthetic blood and is not hemoglobin-based. Particular focus is given to the target application of Oxycyte, which is being developed...

  • Effects of N-Acetyl-L-Cysteine and Hyaluronic Acid on HBOC-201- Induced Systemic and Cerebral Vasoconstriction in the Rat. Abutarboush, Rania; Pappas, Georgina; Arnaud, Francoise; Auker, Charles; McCarron, Richard; Scultetus, Anke; Moon-Massat, Paula F. // Current Drug Delivery;Dec2013, Vol. 10 Issue 4, p315 

    Hemoglobin-based oxygen carrier-201 (HBOC) was developed as a resuscitative fluid but concerns exist over potentially adverse vasoconstriction. This study evaluated whether concurrent IV (intra venous) N-acetyl-L-cysteine (NAC) or hyaluronic acid (HA) would attenuate HBOC-associated...

  • In protest of HBOC study, Biopure is rebuffed by JAMA. Yoffee, Lynn // Medical Device Daily;6/11/2008, Vol. 12 Issue 112, p1 

    The article reports on the potential health risks associated with hemoglobin-based oxygen carriers (HBOC). Findings of clinical trials, published in the "Journal of the American Medical Association," showed that HBOC could increase the risks of heart attack and death. However, Biopure, which...

  • Gender-specific transfusion affects tumor-associated neutrophil: macrophage ratios in murine pancreatic adenocarcinoma. Benson, Douglas D.; Kelher, Marguerite R.; Meng, Xianzhong; Fullerton, David A.; Lee, Joon H.; Silliman, Christopher C.; Barnett Jr., Carlton C.; Barnett, Carlton C Jr // Journal of Gastrointestinal Surgery;Oct2010, Vol. 14 Issue 10, p1560 

    Introduction: Perioperative blood transfusion has been linked to decreased survival for pancreas cancer. Noting clinical data associating female blood products with increased morbidity, our lab has demonstrated that transfusion of female blood augments metastatic events compared to...

  • Oxygen Therapeutics. Ness, Paul M.; Cushing, Melissa M. // Archives of Pathology & Laboratory Medicine;May2007, Vol. 131 Issue 5, p734 

    Context.—There is no true substitute for the many functions of human red blood cells, and synthetic products will not replace the need for blood donation in the foreseeable future. Hemoglobin-based oxygen carriers have many characteristics that would serve as a useful adjunct to red cells...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics